Historical record - last NADAC publication: 4/17/2024
Product Information
RIZATRIPTAN 10 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.3204 per EA under NDC 69097086617. Its NADAC has been published 297 times since Sep 12, 2018.
Strength
10 mg/1
Manufacturer
Cipla USA Inc.NDC
69097086617
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
4/17/2024
Active Ingredients
RIZATRIPTAN BENZOATEApproval Type
Generic (ANDA)
FDA Application
ANDA204339On Market Since
7/22/2016
Pharmacological Classes
Price Statistics
The NADAC for RIZATRIPTAN 10 MG TABLET has been published 297 times since Sep 12, 2018, and over the history we have for it it has declined 60.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3204 per EA |
|---|---|
| All-time high | $0.8270 (Jun 12, 2019) |
| All-time low | $0.3204 (Apr 17, 2024) |
| Median price | $0.5960 |
| Average price | $0.5790 |
| Largest weekly change | +30.1% (Feb 22, 2023) |
| Weeks tracked | 297 |
| Tracking since | Sep 12, 2018 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIZATRIPTAN 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 10 MG TABLET, manufactured by Cipla USA Inc., is $0.3204 per EA (NDC 69097086617), effective May 15, 2024.
How has the price of RIZATRIPTAN 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for RIZATRIPTAN 10 MG TABLET has declined 60.5%. It has been tracked across 297 weekly CMS publications since Sep 12, 2018.
What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 10 MG TABLET?
Since Sep 12, 2018, the NADAC for RIZATRIPTAN 10 MG TABLET has ranged from a low of $0.3204 (Apr 17, 2024) to a high of $0.8270 (Jun 12, 2019), with a median of $0.5960 per EA.
Are there cheaper alternatives to RIZATRIPTAN 10 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as RIZATRIPTAN 10 MG TABLET, but none are currently priced below it.
Who manufactures RIZATRIPTAN 10 MG TABLET?
RIZATRIPTAN 10 MG TABLET (NDC 69097086617) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification